Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rolf Sauer

Showing results (21-30 of 161) with videos related to

Pageof 17
Sort By:
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 5, 2007
One more change of paradigm in breast cancer treatment. Postmastectomy radiotherapy for patients with one to three lymph node metastases?Marie-Luise Sautter-Bihl, Rolf Sauer
Radiation Oncology (London, England)|July 29, 2011
Gemcitabine/cisplatin versus 5-fluorouracil/mitomycin C chemoradiotherapy in locally advanced pancreatic cancer: a retrospective analysis of 93 patientsThomas B Brunner, Rolf Sauer, Rainer Fietkau
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 3, 2014
[Prof. Dr. med. Thomas G. Wendt Director of the Department of Radiation Oncology at the University Hospital Jena on his 65th birthday]Tilo Wiezorek, Gerhard G Grabenbauer, Rolf Sauer
Brachytherapy|April 6, 2004
The role of pulsed-dose-rate brachytherapy in previously irradiated head-and-neck cancerVratislav Strnad, Matthias Geiger, Michael Lotter, et al.
Breast Care (Basel, Switzerland)|November 25, 2015
Romancing the Boost - the Higher, the Better?Felix Sedlmayer, Marie-Luise Sautter-Bihl, Rolf Sauer
Brachytherapy|April 20, 2004
Pulsed-dose rate brachytherapy with concomitant chemotherapy and interstitial hyperthermia in patients with recurrent head-and-neck cancerMatthias Geiger, Vratislav Strnad, Michael Lotter, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 30, 2002
[Functional and molecular aspects of anti-inflammatory effects of low-dose radiotherapy]Franz Rödel, Friedrich Kamprad, Rolf Sauer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 30, 2007
Quality of interstitial PDR-brachytherapy-implants of head-and-neck-cancers: predictive factors for local control and late toxicity?Winfrid J Melzner, Michael Lotter, Rolf Sauer, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 19, 2003
Significant increase in residual DNA damage as a possible mechanism of radiosensitization by gemcitabineChristian Weiss, Gerhard G Grabenbauer, Rolf Sauer, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 14, 2004
Chemoradiation may prolong survival of patients with non-bulky unresectable extrahepatic biliary carcinoma. A retrospective analysisThomas B Brunner, Dieter Schwab, Thomas Meyer, et al.
Pageof 17

Showing results (21-30 of 161) with videos related to

Sort By:
Pageof 17
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 5, 2007
One more change of paradigm in breast cancer treatment. Postmastectomy radiotherapy for patients with one to three lymph node metastases?Marie-Luise Sautter-Bihl, Rolf Sauer
Radiation Oncology (London, England)|July 29, 2011
Gemcitabine/cisplatin versus 5-fluorouracil/mitomycin C chemoradiotherapy in locally advanced pancreatic cancer: a retrospective analysis of 93 patientsThomas B Brunner, Rolf Sauer, Rainer Fietkau
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 3, 2014
[Prof. Dr. med. Thomas G. Wendt Director of the Department of Radiation Oncology at the University Hospital Jena on his 65th birthday]Tilo Wiezorek, Gerhard G Grabenbauer, Rolf Sauer
Brachytherapy|April 6, 2004
The role of pulsed-dose-rate brachytherapy in previously irradiated head-and-neck cancerVratislav Strnad, Matthias Geiger, Michael Lotter, et al.
Breast Care (Basel, Switzerland)|November 25, 2015
Romancing the Boost - the Higher, the Better?Felix Sedlmayer, Marie-Luise Sautter-Bihl, Rolf Sauer
Brachytherapy|April 20, 2004
Pulsed-dose rate brachytherapy with concomitant chemotherapy and interstitial hyperthermia in patients with recurrent head-and-neck cancerMatthias Geiger, Vratislav Strnad, Michael Lotter, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 30, 2002
[Functional and molecular aspects of anti-inflammatory effects of low-dose radiotherapy]Franz Rödel, Friedrich Kamprad, Rolf Sauer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 30, 2007
Quality of interstitial PDR-brachytherapy-implants of head-and-neck-cancers: predictive factors for local control and late toxicity?Winfrid J Melzner, Michael Lotter, Rolf Sauer, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 19, 2003
Significant increase in residual DNA damage as a possible mechanism of radiosensitization by gemcitabineChristian Weiss, Gerhard G Grabenbauer, Rolf Sauer, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 14, 2004
Chemoradiation may prolong survival of patients with non-bulky unresectable extrahepatic biliary carcinoma. A retrospective analysisThomas B Brunner, Dieter Schwab, Thomas Meyer, et al.
Pageof 17